Dr Christopher Kobylecki is a Consultant Neurologist at Greater Manchester Neurosciences Centre, Salford and Honorary Senior Lecturer in Clinical and Cognitive Neurosciences at the University of Manchester. He completed a PhD focused on mechanisms of L-DOPA-induced abnormal involuntary movements in Parkinson’s disease (PD) whilst undertaking higher clinical training in neurology, including clinical trials in PD. He undertook postdoctoral research focused on the use of positron emission tomography (PET) and MR imaging in parkinsonian syndromes and neurodegenerative dementias. He runs a specialist movement disorder clinic at Salford Royal and is involved in the regional service for patients with atypical parkinsonism and dystonia, as well as being a lead for advanced therapies (particularly apomorphine and Duodopa). His research interests include motor complications of PD, cognitive and non-motor disorders in PD and atypical parkinsonism, and dystonia.